OSR Health Receives Nasdaq Staff Delisting Determination and Intends to Request Hearings Panel Appeal
OSR Health received a Staff Delisting Determination from Nasdaq notifying the company that its securities are subject to delisting due to a failure to regain compliance with the minimum bid price requirement. The company intends to appeal the decision, citing extraordinary trading volume of approximately 370 million shares on August 17 and an intraday high of $0.84 on August 18, which was close to the $1.00 threshold.
Key figures
- Suspension date
- 2026-08-26
- Public float shares
- 18.5 million
- Intraday high aug 18
- $0.84
- Shares traded aug 17
- 370 million
- Shares traded aug 18
- 145 million
- Compliance threshold bid price
- $1.00
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.